Literature DB >> 18185104

Subthalamic stimulation increases striatal tyrosine hydroxylase phosphorylation.

Rene Reese1, Christine Winter, Agnes Nadjar, Daniel Harnack, Rudolf Morgenstern, Andreas Kupsch, Erwan Bezard, Wassilios Meissner.   

Abstract

Subthalamic stimulation enhances striatal tyrosine hydroxylase activity, which is regulated by phosphorylation at different serine residues. Western blotting was performed to investigate phosphorylation at the serine residues 19, 31 and 40 in striatal tissue of rats that had received subthalamic stimulation or sham stimulation for 2 h. In animals that were killed directly after stimulation, the tyrosine hydroxylase protein content was unchanged, whereas phosphorylation at the serine residue 19 was increased and phosphorylation at the serine residues 31 and 40 tended to be higher compared with controls. By contrast, tyrosine hydroxylase protein content and phosphorylation were similar in rats that were killed 24 h after stimulation. Our results suggest that subthalamic stimulation may increase tyrosine hydroxylase activity via increased phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18185104     DOI: 10.1097/WNR.0b013e3282f417b4

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

Review 1.  [Deep brain stimulation for neurological and psychiatric diseases: animal experiments on effect and mechanisms].

Authors:  C Winter; D Harnack; A Kupsch
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

2.  ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Authors:  Michael F Salvatore
Journal:  J Neurochem       Date:  2014-01-27       Impact factor: 5.372

Review 3.  Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature.

Authors:  Amit Chopra; Susannah J Tye; Kendall H Lee; Shirlene Sampson; Joseph Matsumoto; Andrea Adams; Bryan Klassen; Matt Stead; Julie A Fields; Mark A Frye
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.